Member Info for Ducati2

https://www.itv.com/news/2020-11-16/vaccine-on-its-own-wont-end-covid-pandemic-director-general-of-who-warns

The director general of the World Health Organization (WHO) has said that a coronavirus vaccine on its own will not end the pandemic as the virus will still have "room to move".

Dr Tedros Adhanom Ghebreyesus told the global health body’s executive board meeting: “Since the beginning of the pandemic, we knew that a vaccine would be essential for bringing the pandemic under control.

“But it’s important to emphasise that a vaccine will complement the other tools we have, not replace them. A vaccine on its own will not end the pandemic."

He said with limited supplies initially, health workers, older people and other at-risk populations will be prioritised.

"That will hopefully reduce the number of deaths and enable health systems to cope," he said.

https://www.pmlive.com/pharma_news/synairgens_sng001_advances_into_phase_3_covid-19_trial_1356928

Moderna vaccine ?

News prior to event...........

https://www.sharesoc.org/events/sharesoc-webinar-with-synairgen-sng-18-november-2020/

https://www.bbc.co.uk/news/health-54949799

https://www.politico.com/newsletters/prescription-pulse/2020/11/13/a-new-health-agenda-under-biden-eventually-791623

INHALED INTERFERON PROVES PROMISING IN SMALL TRIAL — An inhaled coronavirus drug showed promise in helping those hospitalized with the condition in a small U.K. trial, according to results published Thursday in The Lancet Respiratory Medicine.

The placebo-controlled trial of about 100 patients is the first to show that an inhaled version of a naturally occurring protein called interferon beta-1a may help those hospitalized with Covid-19 recover faster and decrease their chances of developing severe symptoms.

"I think it looks promising and would be something that should be studied in more detail," said Amesh Adalja, an infectious disease doctor at the Johns Hopkins Center for Health Security, who was not involved with the trial. "I would be interested in seeing if there would be more improvement if the treatment was given earlier and how this drug fares in patients getting other therapies such as dexamethasone."

https://www.nbcnews.com/health/health-news/breakthrough-finding-reveals-why-certain-covid-19-patients-die-n1247576

https://www.fda.gov/media/136832/download

The FDA and other government partners are working with industry to make treatment options available to patients and providers who are not able to participate in clinical trials, including through expanded access under investigational new drug (IND) applications.
Additionally, if certain statutory criteria are met, the FDA may issue an emergency use authorization (EUA) to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life- threatening diseases or conditions caused by chemical, biological, radiological, or nuclear threat agents when, among other factors, there are no adequate, approved, and available alternatives.
As of September 16, 2020, the FDA has authorized six EUAs, and revoked one of the initial six, to treat COVID and serious conditions caused by COVID-19:

Trueway

AIM is one almighty Gamble..........

I hold stock in BRH and RMS and the roulette wheel is spinning!

I also hold stock in SNG and these are for PHASE 111 completion or the Sale, you pay your money and take your chance........ Might see you on the other boards but it looks as if that’s your last post here.........Good luck and goodbye.

Yes you are too late for these shares.

The purpose of this Phase III study is to confirm that SNG001 can accelerate the recovery to ‘no limitation of activities’ of hospitalised patients receiving oxygen with confirmed SARS-CoV-2. Safety and other efficacy endpoints will also be assessed.

https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/phase-iii-trial-of-inhaled-anti-viral-sng001-for-sars-cov-2-covid-19-uph/

https://www.nihr.ac.uk/covid-studies/

https://twitter.com/VirusesImmunity

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2...
Patients who received SNG001 had greater odds of improvement and recovered more rapidly from SARS-CoV-2 infection than patients who received placebo, providing a strong rationale for further trials.
thelancet.com

https://www.nbcnews.com/health/health-news/breakthrough-finding-reveals-why-certain-covid-19-patients-die-n1247576

https://www.ig.com/uk/news-and-trade-ideas/will-synairgen-shares-keep-soaring-on-new-covid-19-treatment--201113

H & L

Buy 128...........Sell.......130

https://www.youtube.com/watch?v=yv1Qxw80x6c

https://news.sky.com/story/covid-19-new-protein-treatment-reduces-odds-of-developing-severe-coronavirus-12130866

https://www.londonstockexchange.com/stock/SNG/synairgen-plc/analysis?lang=en

https://pharmafield.co.uk/opinion/implications-of-early-covid-19-vaccine-data/

About time the Government got their fingers out..........

https://news.sky.com/story/covid-19-you-are-literally-fighting-for-your-breath-inside-intensive-care-unit-battling-deadly-second-wave-12130038